The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 1,393–1,416 of 11,281
ArticlePsilocybin

Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study.

Poppe C, Lyck L, Bechtold L +1

Europe PMC2026
ArticlePsilocybin

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

Stocker K, Hartmann M, Barrett FS +6

Europe PMC2026
TrialPsilocybin

Psilocybin-Assisted Therapy as a Treatment for Depression

ClinicalTrials.gov2026
ArticleKetamine

Ketamine Dosing Across Clinical Indications: A Narrative Review Organized by Proposed NMDA-Related Mechanisms.

Glue P, Beaglehole B

Europe PMC2026
ArticlePsilocybin

Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex.

Houff J, Williams A, Allen O 4th +3

Europe PMC2026
ArticlePsilocybin

Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study.

Jungwirth J, Westenhöfer S, Aicher HD +5

Europe PMC2026
ArticlePsilocybin

Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes.

Rowe T, Hurzeler T, Towers E +2

Europe PMC2026
PreprintPsilocybin

Reorganization of Human Brain Waves Across Diverse States of Consciousness

Fotiadis P, Jang H, Dai R +6

Europe PMC2026
TrialPsilocybin

A Study of Psychedelics in Healthy Older Adults With Low Well-being

ClinicalTrials.gov2026
ArticleDMT

GH001 Efficacy is Independent of Prior Antidepressant Treatment Failures in Treatment-Resistant Depression: A Post Hoc Analysis of a Phase 2b Randomized Controlled Trial.

Thase ME, Brennan B, MacIsaac R +3

Europe PMC2026
TrialPsilocybin

Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression

ClinicalTrials.gov2026
TrialKetamine

Esketamine Versus Crisis Response Planning Versus Enhanced Treatment as Usual for Suicide Prevention: A Pragmatic Randomized Trial in a Brazilian Municipality (SAVE)

ClinicalTrials.gov2026
TrialKetamine

Intranasal Dexmedetomidine or Esketamine for Negative Postoperative Behavioral Changes in Children

ClinicalTrials.gov2026
TrialKetamine

Multimodal Opioid-Free Anesthesia in RIRS

ClinicalTrials.gov2026
ArticleDMT

Time-resolved Neural and Experience Dynamics of Medium- and High-dose N,N-Dimethyltryptamine (DMT).

Lewis-Healey E, Pallavicini C, Cavanna F +7

Europe PMC2026
ArticlePsilocybin

Studies on enzymatic hydrolysis of psilocin-O-glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometry.

Barajas DA, Carter HCN, Tomedi MR +5

Europe PMC2026
PreprintPsilocybin

Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional survey

Li EJ, Mosharraf B, Ali H +9

Europe PMC2026
TrialKetamine

Ketamine in Severe Traumatic Brain Injury

ClinicalTrials.gov2026
TrialKetamine

Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression

ClinicalTrials.gov2026
ArticleKetamine

Ketamine Immediate Analgesia and Opioid-Sparing Benefits in Laparoscopic Cholecystectomy: A Meta-Analysis of Time Points, Anesthesia Protocols, and Bolus/Infusion Strategies.

Abo Zeid M, Abou Elezz AM, Khalefa K +6

Europe PMC2026
ArticleKetamine

Role of Opioid-Free Anesthesia Versus Opioid-Based Anesthesia in Postoperative Pain and Opioid Consumption: A Systematic Review and Meta-Analysis

Ayazbekova A, Khan A, Yerzhan A +2

Europe PMC2026
ArticleKetamine

Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery

Europe PMC2026
ArticleKetamine

Synaptic Plasticity-Intrinsic Excitability and Antidepressant Discovery.

Tanaka M

Europe PMC2026
ArticleIbogaine

Ibogaine in the Vet Brain: Changes in Brain Metabolism and Connectivity After Ibogaine Administration in Veterans With Traumatic Brain Injury.

Fonzo GA

Europe PMC2026